Stock Name: RafflesMG
Company Name: RAFFLES MEDICAL GROUP LTD
DMG & Partners Research in an Apr 30 research report says: "Raffles Medical just released its 1Q12 results this morning, which were slightly ahead of our expectations. Revenue grew 13.2% to $72. million with all divisions of the Group contributing. Sales from hospital services and healthcare services divisions increased by 15.3% and 7.4% respectively.
"Net earnings grew 10.5% to $11.7 million, driven by higher patient load and patient acuity. It has already appointed consultants to work on the seven storey Thong Sia Building in Orchard area with a total floor area of 42,668 sf to retrofit it and expand its specialist centre operations.
"This, together with the expansion of its flagship hospital at North Bridge Road, should contribute positively to the Group in the next few years. Target price of $2.67. BUY"
Company Name: RAFFLES MEDICAL GROUP LTD
| Research House: DMG | Price Call: BUY | Target Price: 2.67 |
DMG & Partners Research in an Apr 30 research report says: "Raffles Medical just released its 1Q12 results this morning, which were slightly ahead of our expectations. Revenue grew 13.2% to $72. million with all divisions of the Group contributing. Sales from hospital services and healthcare services divisions increased by 15.3% and 7.4% respectively.
"Net earnings grew 10.5% to $11.7 million, driven by higher patient load and patient acuity. It has already appointed consultants to work on the seven storey Thong Sia Building in Orchard area with a total floor area of 42,668 sf to retrofit it and expand its specialist centre operations.
"This, together with the expansion of its flagship hospital at North Bridge Road, should contribute positively to the Group in the next few years. Target price of $2.67. BUY"
No comments:
Post a Comment